79 related articles for article (PubMed ID: 8289476)
21. Use of a temperature-sensitive mutant to define the biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line.
Carlesso N; Griffin JD; Druker BJ
Oncogene; 1994 Jan; 9(1):149-56. PubMed ID: 8302574
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase.
Miyazawa K; Hendrie PC; Mantel C; Wood K; Ashman LK; Broxmeyer HE
Exp Hematol; 1991 Dec; 19(11):1110-23. PubMed ID: 1721591
[TBL] [Abstract][Full Text] [Related]
23. Bcr-Abl regulates osteopontin transcription via Ras, PI-3K, aPKC, Raf-1, and MEK.
Hickey FB; England K; Cotter TG
J Leukoc Biol; 2005 Jul; 78(1):289-300. PubMed ID: 15857938
[TBL] [Abstract][Full Text] [Related]
24. BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon.
Liu J; Campbell M; Guo JQ; Lu D; Xian YM; Andersson BS; Arlinghaus RB
Oncogene; 1993 Jan; 8(1):101-9. PubMed ID: 8423987
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.
Ellis C; Moran M; McCormick F; Pawson T
Nature; 1990 Jan; 343(6256):377-81. PubMed ID: 1689011
[TBL] [Abstract][Full Text] [Related]
26. BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl.
Hemmeryckx B; Reichert A; Watanabe M; Kaartinen V; de Jong R; Pattengale PK; Groffen J; Heisterkamp N
Oncogene; 2002 May; 21(20):3225-31. PubMed ID: 12082638
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.
Sepp-Lorenzino L; Eberhard I; Ma Z; Cho C; Serve H; Liu F; Rosen N; Lupu R
Oncogene; 1996 Apr; 12(8):1679-87. PubMed ID: 8622888
[TBL] [Abstract][Full Text] [Related]
28. Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR - ABL tyrosine kinase, CGP 57148.
Dan S; Naito M; Tsuruo T
Cell Death Differ; 1998 Aug; 5(8):710-5. PubMed ID: 10200527
[TBL] [Abstract][Full Text] [Related]
29. A coiled-coil tetramerization domain of BCR-ABL is essential for the interactions of SH2-containing signal transduction molecules.
Tauchi T; Miyazawa K; Ohyashiki K; Toyama K
Hum Cell; 1996 Dec; 9(4):333-6. PubMed ID: 9183666
[TBL] [Abstract][Full Text] [Related]
30. Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
Nieborowska-Skorska M; Slupianek A; Skorski T
Oncogene; 2000 Aug; 19(36):4117-24. PubMed ID: 10962572
[TBL] [Abstract][Full Text] [Related]
31. Ontogenic regulation of phospholipase C-gamma 1 activity and expression in the rat small intestine.
Polk DB
Gastroenterology; 1994 Jul; 107(1):109-16. PubMed ID: 8020653
[TBL] [Abstract][Full Text] [Related]
32. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells.
Carpino N; Wisniewski D; Strife A; Marshak D; Kobayashi R; Stillman B; Clarkson B
Cell; 1997 Jan; 88(2):197-204. PubMed ID: 9008160
[TBL] [Abstract][Full Text] [Related]
33. Human ltk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo.
Kozutsumi H; Toyoshima H; Hagiwara K; Yazaki Y; Hirai H
Oncogene; 1994 Oct; 9(10):2991-8. PubMed ID: 8084603
[TBL] [Abstract][Full Text] [Related]
34. G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr-Abl-induced transformation and leukemogenesis.
Zuo B; Li M; Liu Y; Li K; Ma S; Cui M; Qin Y; Zhu H; Pan X; Guo J; Dai Z; Yu W
Leuk Lymphoma; 2015 Jul; 56(7):2170-81. PubMed ID: 25363403
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines.
Druker B; Okuda K; Matulonis U; Salgia R; Roberts T; Griffin JD
Blood; 1992 May; 79(9):2215-20. PubMed ID: 1571536
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity.
Kashige N; Carpino N; Kobayashi R
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2093-8. PubMed ID: 10688886
[TBL] [Abstract][Full Text] [Related]
37. Beyond Philadelphia: 'Ph-like' B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises.
Izraeli S
Curr Opin Hematol; 2014 Jul; 21(4):289-96. PubMed ID: 24848770
[TBL] [Abstract][Full Text] [Related]
38. A protein that is highly related to GTPase-activating protein-associated p62 complexes with phospholipase C gamma.
Maa MC; Leu TH; Trandel BJ; Chang JH; Parsons SJ
Mol Cell Biol; 1994 Aug; 14(8):5466-73. PubMed ID: 7518563
[TBL] [Abstract][Full Text] [Related]
39. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family.
Reuther GW; Fu H; Cripe LD; Collier RJ; Pendergast AM
Science; 1994 Oct; 266(5182):129-33. PubMed ID: 7939633
[TBL] [Abstract][Full Text] [Related]
40. Patterns of tyrosine phosphorylation differ in vascular hypertrophy and hyperplasia.
Ali S; Dorn GW
Am J Physiol; 1994 Dec; 267(6 Pt 1):C1674-81. PubMed ID: 7810610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]